FDA Enforcement
The Food and Drug Administration is responsible for enforcing the federal Food, Drug and Cosmetic Act. It enforces that law and related regulations to ensure compliance by every entity involved with a regulated product.
This includes regulation of processes involved in:
- Design
- Production of components and finished products
- Packaging, and
- Post-production processes like sterilization, labeling and distribution, and post-market surveillance; until the end of the effective life cycle of that product.
FDA Enforcement Tools
The FDA uses several regulatory tools to maintain cognizance over the safety and efficacy of regulated products.
One of the agency’s primary enforcement tools is on-site inspections performed by FDA inspectors, which can result in “483” noncompliance findings that often lead to warning letters and other enforcement actions.
Other tools include enforcing requirements for the market approval of products, documentation of manufacturer and supplier regulated processes, and reporting of product issues, among others. It also utilizes several methods to notify the public of product issues and health threats they may present.
The FDA communicates to manufacturers and other responsible parties to issue warnings, invoke punishments, and require enforcement actions like product recalls and corrections. And although the agency shares that information on its website it can be difficult and time-consuming to find the specific, most recent information.
Medical Devices and Pharma presents the various types of FDA information in a format and structure that makes it more accessible to consumers and industry.
FDA Enforcement Posts
Major Quality System Failures at Cardiac Device Manufacturer
Agency cites device classification disputes, inadequate manufacturing controls, and quality system deficiencies dating back to 2011An August 26,...
FDA Warning Letter for Stem Cell and Placenta Products
FDA challenges claims that biological products can treat serious diseases without demonstrating their safety and effectiveness through the agency's...
FDA Challenges Tides Medical’s Class I Device Classification
FDA's warning letter to Tides Medical illustrates how a device's intended use, not its manufacturer's chosen product code, determines its regulatory...
FDA Warning Letter to AHC Products, Inc. for CGMP Violations
FDA Warning Letter to AHC Products, Inc. for CGMP Violations The U.S. Food and Drug Administration (FDA) has issued a Warning Letter to AHC...
FDA Warning Letters Target Online Ketamine Sellers
Seven Warning Letters Signal Increased FDA Scrutiny The U.S. Food and Drug Administration (FDA) has launched a coordinated enforcement action...
FDA Warns Wild Arabic Herbs Over Product Cancer Claims
FDA Warns Wild Arabic Herbs Over Cancer Claims for Herbal Product FDA issued a warning letter to Wild Arabic Herbs after reviewing the company’s...
FDA Warns Amazon for Unapproved Drugs Sold On Its Website
FDA Issues Warning Letter to Amazon for Unapproved Drug Products FDA issued a warning letter to Amazon.com, Inc. after purchasing and reviewing...
FDA Warns Leading Edge Health Over Unapproved New Drugs
FDA Warning Letter Targets Erectin Stimulating Gel and VigRX Delay Wipes FDA issued a warning letter to Leading Edge Health Inc. after reviewing the...
FDA Targets Online Marketing of Unapproved Drugs
FDA Issues 14 Warning Letters Targeting Online Unapproved Drug Sales The U.S. Food and Drug Administration (FDA) has issued a coordinated series of...
FDA Issues Warning Letter for Modifications to Infant Products
FDA Issues Warning Letter to Happiest Baby Over SNOO Smart Sleeper Modifications and Quality System Deficiencies The U.S. Food and Drug...

